Xeris Biopharma Holdings (XERS) Assets (2020 - 2026)
Xeris Biopharma Holdings' Assets was $411.91 million in Q2 2026, up 23.1% from $334.69 million a year earlier and up 5.1% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Assets at Xeris Biopharma Holdings came in at $383.53 million, up 18.7% from FY2024.
- Assets shows a five-year compound annual growth rate of 19.2% (FY2020 to FY2025).
- In earlier years, Assets was $323.06 million in FY2024 (+0.1%), $322.6 million in FY2023 (-6.4%), $344.52 million in FY2022 (+13.2%) and $304.36 million in FY2021 (+91.2%).
- The Q2 2026 figure marks the highest quarterly Assets in data going back to Q4 2020.
- Compared with a year earlier, Assets has increased for five straight quarters, with growth averaging 9.3% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q3 2022 (growth of 130.9%); the worst was Q4 2023 (a decline of 6.4%).
- Per Business Quant data, XERS's Assets in the three quarters before Q2 2026 was $392.01 million (Q1 2026), $383.53 million (Q4 2025) and $370.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Xeris Biopharma Holdings | 1.71 Bn | 1.27 Bn | 79.59 Mn | 411.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 411.91 Mn |
| Mar 31, 2026 | 392.01 Mn |
| Dec 31, 2025 | 383.53 Mn |
| Sep 30, 2025 | 370.19 Mn |
| Jun 30, 2025 | 334.69 Mn |
| Mar 31, 2025 | 315.45 Mn |
| Dec 31, 2024 | 323.06 Mn |
| Sep 30, 2024 | 321.10 Mn |
| Jun 30, 2024 | 331.73 Mn |
| Mar 31, 2024 | 336.62 Mn |
| Dec 31, 2023 | 322.60 Mn |
| Sep 30, 2023 | 327.78 Mn |
| Jun 30, 2023 | 328.78 Mn |
| Mar 31, 2023 | 321.36 Mn |
| Dec 31, 2022 | 344.52 Mn |
| Sep 30, 2022 | 303.02 Mn |
| Jun 30, 2022 | 318.62 Mn |
| Mar 31, 2022 | 337.62 Mn |
| Dec 31, 2021 | 304.36 Mn |
| Sep 30, 2021 | 131.26 Mn |
API Access
Xeris Biopharma Holdings Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();